Oral Presentations Workshop 3. New therapies targeting the airway surface| Volume 15, SUPPLEMENT 1, S6, June 2016

WS03.6 Study of Mul-1867, a drug candidate for inhalation therapy of pulmonary exacerbations in patients with cystic fibrosis against mixed infections caused by clinical isolates of P. aeruginosa, S. aureus and C. albicans in murine lung infection model

      This paper is only available as a PDF. To read, Please Download here.